Funding, News and Announcements
» Go to news mainFunding translational cancer immunotherapy research
BioCanRx is excited to announce the second intake for their rolling, open call process to fund new opportunities in translational cancer immunotherapy research. They are now accepting letters of intent for the following four research programs:
· Clinical Trials Program
· Enabling Studies Program
· Catalyst Program
· Clinical, Social and Economic Impact ProgramÂ
The next intake deadline for these letters of intent is July 29, 2016, by 11:59 p.m. ET.
For research program details and more information about the open call application process, . This funding opportunity is available to any investigator in a Canadian institution eligible to receive funding from CIHR, NSERC and SSHRC.
Recent News
- The Association of Commonwealth Universities (ACU) Funding Opportunities 2024‑25
- Social Sciences and Humanities Research Council
- Global Research Fund
- Genome Canada
- NS‑USA Subsea Cable Socioeconomic Study
- CIHR Institute of Cancer Research
- Webinar in Equity, Diversity and Inclusion (EDI)
- Nova Scotia Office of Addictions and Mental Health